We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Three European Scientists Awarded Medicine Prize

By Biotechdaily staff writers
Posted on 22 Jan 2003
The Louis-Jeantet Foundation for Medicine (Geneva, Switzerland) has announced that three innovative scientists in Europe have been awarded the foundation's 2003 Prize for Medicine. More...
The prize has been awarded every year since 1986 and its mission is to foster innovative biomedical research in Europe. Winners, who must be engaged in basic or clinical medical research, receive a cumulative award amounting to a maximum of 1.2 million euros to carry out their research projects, as well as a personal prize.

Wolfgang Baumeister, director of the Max-Planck Institute for Biochemistry (Martinsried, Germany), won for his work on the proteasome and for the further development of cryoelectron tomography. This method uses an electron microscope but analyzes objects in a rapidly frozen state that preserves their structure. With the prize, Prof. Baumeister proposes to push electron tomography to still higher resolution and to investigate the 3D architecture of the molecular complexes that form the synapses of nerve cells. Prof. Baumeister is a citizen of Germany.

Riitta Hari, a professor at the Academy of Finland and the head of the Brain Research Unit at the Low Temperature Laboratory of Helsinki University of Technology (Finland), won for her work in improving magnetoencephalography (MEG), which detects tiny changes in the magnetic field associated with brain activity. With the prize, Prof. Hari plans to study the effects of observed pain on brain activation of the observer, in order to contribute to our understanding of the neural basis of social cognition. Prof. Hari is a citizen of Germany.

Nikos Logothetis, director of the Max-Planck Institute for Biological Cybermetics and head of the department of physiology of cognitive processes in Tubingen (Germany), won for his progress in understanding the perception of visual images by the brain, working with trained monkeys. This led to the discovery that changes in local oxygenation, measured by functional magnetic resonance imaging (fMRI), are the result of incoming signals rather than outgoing action potentials. With the prize, he wants to develop new biochemical probes that detect neuronal activity in real-time. Prof. Logothetis is a citizen of Greece.




Related Links:
Max Planck, Martinsried
Helsinki U.
Max-Planck, Tubingen

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.